Literature DB >> 10947199

Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy.

Y Suzuki1, K Isogai, T Teramoto, H Tashita, N Shimozawa, M Nishimura, T Asano, M Oda, A Kamei, H Ishiguro, S Kato, T Ohashi, H Kobayashi, Y Eto, N Kondo.   

Abstract

The effects of bone marrow transplantation (BMT) in X-linked childhood adrenoleukodystrophy (ALD) are described in four Japanese patients. Two older patients, 10-year-old boys with IQ 60 and difficulty in school, had favourable results. IQ levels and MRI findings were generally maintained after BMT. One patient showed improvement of gait disturbance. They have both attended ordinary schools after BMT, although a learning disorder persists. On the other hand, two other younger patients with a rapid course and indeterminate IQ at BMT showed deterioration of neurological functions. Indication for BMT seems to be a maintained IQ level, preferably higher than 80, since it seems to be difficult to normalize IQ level after BMT. Younger patients have higher risk of developing a rapidly progressive form of the disease. Identification of presymptomatic boys, and serial and careful follow-up by neuropsychological and neuroradiological studies, are essential prerequisites to successful BMT in X-ALD.

Entities:  

Mesh:

Year:  2000        PMID: 10947199     DOI: 10.1023/a:1005656029200

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  15 in total

1.  Treatment of adrenoleukodystrophy with bone marrow transplantation.

Authors:  G Malm; O Ringdén; M Anvret; U von Döbeln; L Hagenfeldt; B Isberg; S Knuutila; I Nennesmo; J Winiarski; C Marcus
Journal:  Acta Paediatr       Date:  1997-05       Impact factor: 2.299

Review 2.  The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome.

Authors:  W Krivit; L A Lockman; P A Watkins; J Hirsch; E G Shapiro
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Reappearance of visual and somatosensory evoked potentials in a patient with childhood adrenoleukodystrophy after bone marrow transplantation and dietary erucic acid therapy.

Authors:  M Inagaki; Y Maegaki; K Ohtani; J Asano; Y Suzuki
Journal:  Acta Paediatr Jpn       Date:  1995-02

4.  Identification of a nonsense mutation in ALD protein cDNA from a patient with adrenoleukodystrophy.

Authors:  A Uchiyama; Y Suzuki; X Q Song; T Fukao; A Imamura; S Tomatsu; N Shimozawa; N Kondo; T Orii
Journal:  Biochem Biophys Res Commun       Date:  1994-01-28       Impact factor: 3.575

5.  Bone marrow transplant in adrenoleukodystrophy.

Authors:  H W Moser; P J Tutschka; F R Brown; A E Moser; A M Yeager; I Singh; S A Mark; A A Kumar; J M McDonnell; C L White
Journal:  Neurology       Date:  1984-11       Impact factor: 9.910

6.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245

7.  Childhood cerebral form of adrenoleukodystrophy: short-term effect of bone marrow transplantation on brain MR observations.

Authors:  D J Loes; A E Stillman; S Hite; E Shapiro; L Lockman; R E Latchaw; H Moser; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

8.  Adrenoleukodystrophy: a scoring method for brain MR observations.

Authors:  D J Loes; S Hite; H Moser; A E Stillman; E Shapiro; L Lockman; R E Latchaw; W Krivit
Journal:  AJNR Am J Neuroradiol       Date:  1994-10       Impact factor: 3.825

9.  Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.

Authors:  J Mosser; A M Douar; C O Sarde; P Kioschis; R Feil; H Moser; A M Poustka; J L Mandel; P Aubourg
Journal:  Nature       Date:  1993-02-25       Impact factor: 49.962

10.  Dietary erucic acid therapy for X-linked adrenoleukodystrophy.

Authors:  W B Rizzo; R T Leshner; A Odone; A L Dammann; D A Craft; M E Jensen; S S Jennings; S Davis; R Jaitly; J A Sgro
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

View more
  4 in total

1.  Diffusion tensor imaging in cases of adrenoleukodystrophy: preliminary experience as a marker for early demyelination?

Authors:  Jacques F L Schneider; Kamil A Il'yasov; Eugen Boltshauser; Jürgen Hennig; Ernst Martin
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Mechanisms of Antioxidant Induction with High-Dose N-Acetylcysteine in Childhood Cerebral Adrenoleukodystrophy.

Authors:  Reena V Kartha; Jie Zhou; Lisa Basso; Henning Schröder; Paul J Orchard; James Cloyd
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

3.  The Role of MR Imaging in the Assessment of Clinical Outcomes in Children with X-Linked Adrenoleukodystrophy after Allogeneic Haematopoietic Stem Cell Transplantation.

Authors:  Joanna Bladowska; Dominika Kulej; Anna Biel; Anna Zimny; Krzysztof Kałwak; Joanna Owoc-Lempach; Julita Porwolik; Teresa Joanna Stradomska; Urszula Zaleska-Dorobisz; Marek J Sąsiadek
Journal:  Pol J Radiol       Date:  2015-04-10

4.  Serum very long-chain fatty acids (VLCFA) levels as predictive biomarkers of diseases severity and probability of survival in peroxisomal disorders.

Authors:  Teresa Joanna Stradomska; Małgorzata Syczewska; Ewa Jamroz; Agata Pleskaczyńska; Piotr Kruczek; Elżbieta Ciara; Anna Tylki-Szymanska
Journal:  PLoS One       Date:  2020-09-18       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.